{"doc_id": "PMID-10358154.txt", "sent_id": "S1", "tokens": ["New", "immunosuppressive", "drug", "PNU156804", "blocks", "IL-2", "-", "dependent", "proliferation", "and", "NF-kappa", "B", "and", "AP-1", "activation", "."], "sentence": "New immunosuppressive drug PNU156804 blocks IL-2 - dependent proliferation and NF-kappa B and AP-1 activation .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "IL-2", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "", "tokens": ["We", "had", "previously", "shown", "that", "the", "drug", "undecylprodigiosin", "(", "UP", ")", "blocks", "human", "lymphocyte", "proliferation", "in", "vitro", "."], "sentence": "We had previously shown that the drug undecylprodigiosin ( UP ) blocks human lymphocyte proliferation in vitro .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10358154.txt", "sent_id": "", "tokens": ["We", "have", "now", "investigated", "the", "mechanism", "of", "action", "of", "a", "new", "analogue", "of", "UP", ",", "PNU156804", ",", "which", "shows", "a", "more", "favorable", "activity", "profile", "than", "UP", "in", "mice", "."], "sentence": "We have now investigated the mechanism of action of a new analogue of UP , PNU156804 , which shows a more favorable activity profile than UP in mice .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10358154.txt", "sent_id": "", "tokens": ["We", "demonstrate", "here", "that", "the", "biological", "effect", "of", "PNU156804", "in", "vitro", "is", "indistinguishable", "from", "UP", ":", "PNU156804", "blocks", "human", "T", "cell", "proliferation", "in", "mid-late", "G1", ",", "as", "determined", "by", "cell", "cycle", "analysis", ",", "expression", "of", "cyclins", ",", "and", "cyclin", "-", "dependent", "kinases", "and", "retinoblastoma", "phosphorylation", "."], "sentence": "We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP : PNU156804 blocks human T cell proliferation in mid-late G1 , as determined by cell cycle analysis , expression of cyclins , and cyclin - dependent kinases and retinoblastoma phosphorylation .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10358154.txt", "sent_id": "S5", "tokens": ["In", "addition", ",", "we", "show", "that", "PNU156804", "does", "not", "block", "significantly", "the", "induction", "of", "either", "IL-2", "or", "IL-2R", "alpha-", "and", "gamma-chains", "but", "inhibits", "IL-2", "-", "dependent", "T", "cell", "proliferation", "."], "sentence": "In addition , we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2 - dependent T cell proliferation .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "block", "start": 9, "end": 9}, "arguments": [{"entity_id": "T11", "text": "induction", "role": "Theme"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 12, "end": 12}, "arguments": [{"entity_id": "T2", "text": "IL-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "IL-2", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T3", "text": "IL-2", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T10", "text": "block", "entity_type": "Negative_regulation", "start": 9, "end": 9}, {"id": "T11", "text": "induction", "entity_type": "Positive_regulation", "start": 12, "end": 12}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "S6", "tokens": ["We", "have", "investigated", "several", "molecular", "pathways", "that", "are", "known", "to", "be", "activated", "by", "IL-2", "in", "T", "cells", "."], "sentence": "We have investigated several molecular pathways that are known to be activated by IL-2 in T cells .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "IL-2", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "S7", "tokens": ["We", "show", "that", "PNU156804", "does", "not", "inhibit", "c-myc", "and", "bcl-2", "mRNA", "induction", "."], "sentence": "We show that PNU156804 does not inhibit c-myc and bcl-2 mRNA induction .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 6, "end": 6}, "arguments": [{"entity_id": "T13", "text": "induction", "role": "Theme"}]}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 6, "end": 6}, "arguments": [{"entity_id": "T13", "text": "induction", "role": "Theme"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 11, "end": 11}, "arguments": [{"entity_id": "T5", "text": "c-myc", "role": "Theme"}]}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 11, "end": 11}, "arguments": [{"entity_id": "T6", "text": "bcl-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T5", "text": "c-myc", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T6", "text": "bcl-2", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T12", "text": "inhibit", "entity_type": "Negative_regulation", "start": 6, "end": 6}, {"id": "T13", "text": "induction", "entity_type": "Positive_regulation", "start": 11, "end": 11}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "", "tokens": ["On", "the", "other", "hand", ",", "PNU156804", "efficiently", "inhibits", "the", "activation", "of", "the", "NF-kappa", "B", "and", "AP-1", "transcription", "factors", "."], "sentence": "On the other hand , PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10358154.txt", "sent_id": "S9", "tokens": ["PNU156804", "inhibition", "of", "NF-kappa", "B", "activation", "is", "due", "to", "the", "inhibition", "of", "the", "degradation", "of", "I", "kappa", "B-alpha", "and", "I", "kappa", "B-beta", "."], "sentence": "PNU156804 inhibition of NF-kappa B activation is due to the inhibition of the degradation of I kappa B-alpha and I kappa B-beta .", "event_mentions": [{"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 10, "end": 10}, "arguments": [{"entity_id": "T15", "text": "degradation", "role": "Theme"}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 10, "end": 10}, "arguments": [{"entity_id": "T15", "text": "degradation", "role": "Theme"}]}, {"id": "E9", "event_type": "Protein_catabolism", "trigger": {"text": "degradation", "start": 13, "end": 13}, "arguments": [{"entity_id": "T8", "text": "I kappa B-beta", "role": "Theme"}]}, {"id": "E10", "event_type": "Protein_catabolism", "trigger": {"text": "degradation", "start": 13, "end": 13}, "arguments": [{"entity_id": "T7", "text": "I kappa B-alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "I kappa B-alpha", "entity_type": "Protein", "start": 15, "end": 17}, {"id": "T8", "text": "I kappa B-beta", "entity_type": "Protein", "start": 19, "end": 21}, {"id": "T14", "text": "inhibition", "entity_type": "Negative_regulation", "start": 10, "end": 10}, {"id": "T15", "text": "degradation", "entity_type": "Protein_catabolism", "start": 13, "end": 13}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "S10", "tokens": ["PNU156804", "action", "is", "restricted", "to", "some", "signaling", "pathways", ";", "it", "does", "not", "affect", "NF-kappa", "B", "activation", "by", "PMA", "in", "T", "cells", "but", "blocks", "that", "induced", "by", "CD40", "cross-linking", "in", "B", "lymphocytes", "."], "sentence": "PNU156804 action is restricted to some signaling pathways ; it does not affect NF-kappa B activation by PMA in T cells but blocks that induced by CD40 cross-linking in B lymphocytes .", "event_mentions": [{"id": "E11", "event_type": "Binding", "trigger": {"text": "cross-linking", "start": 27, "end": 27}, "arguments": [{"entity_id": "T9", "text": "CD40", "role": "Theme"}]}], "entity_mentions": [{"id": "T9", "text": "CD40", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T16", "text": "cross-linking", "entity_type": "Binding", "start": 27, "end": 27}]}
{"doc_id": "PMID-10358154.txt", "sent_id": "", "tokens": ["We", "conclude", "that", "the", "prodigiosin", "family", "of", "immunosuppressants", "is", "a", "new", "family", "of", "molecules", "that", "show", "a", "novel", "target", "specificity", "clearly", "distinct", "from", "that", "of", "other", "immunosuppressive", "drugs", "such", "as", "cyclosporin", "A", ",", "FK506", ",", "and", "rapamycin", "."], "sentence": "We conclude that the prodigiosin family of immunosuppressants is a new family of molecules that show a novel target specificity clearly distinct from that of other immunosuppressive drugs such as cyclosporin A , FK506 , and rapamycin .", "event_mentions": [], "entity_mentions": []}
